investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Clinical Studies to Circumvent Drug Resistance
Susan Bates
2 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Using bioinformatics approaches to identify mechanisms of or pathways involved in drug resistance
Related projects
Sendurai A Mani
Pleiotropic Functions of FOXC2 in EMT, Stem Cells and Breast Cancer Progression
Breast
Anthony J Koleske
Regulation of Invadopodia Formation in Breast Cancer Cells
Breast
Valerie M Weaver
Collagen Remodeling and Tumor Progression
Breast
Kazuaki Takabe
Sphingosine-1-Phosphate in Breast Cancer Progression and Lymphangiogenesis
Breast
Hugh S. Gannon
Extraordinary responder cell lines reveal unique targetable genetic dependencies
Breast
W Todd Miller
Substrate Specificity of Non-receptor Tyrosine Kinases
Breast
Virginia A. Zakian
DNA Replication and Chromosome Structure in Yeast
Breast
Hugo Aerts
Genotype and Imaging Phenotype Biomarkers in Lung Cancer
Trachea, bronchus and lung
Toni Choueiri
Genetic Predictors of Response to mTOR inhibitors in advanced Renal Cancer
Kidney, renal pelvis and ureter
